ArticleJournal of optometry
Multifocal contact lenses and defocus incorporated multiple segments lenses slow myopic progression in Chinese children with high myopia.
Article in Journal of optometry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Comments on: Multifocal contact lenses and defocus incorporated multiple segments lenses slow myopic progression in Chinese children with high myopia.Journal of optometryArticle
- Letter to the editor concerning "Multifocal contact lenses and defocus incorporated multiple segments lenses slow myopic progression in Chinese children with high myopia".Journal of optometryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the efficacy of multifocal soft contact lenses (MFSCLs) and defocus incorporated multiple segments lenses (DIMS) to limit myopic progression in children with high myopia.
methodsThis retrospective study included 249 children (aged 8-16 years) with high myopia (non-cycloplegic spherical equivalent [SE] -6.00 to -10.00 D, astigmatism < 2.00 D). Selected participants were those treated with DIMS (N=81), MFSCLs (DISC, N=60), or single-vision spectacles (SVLs, N=108, control group). Myopic progression was assessed based on the 1-year SE change from baseline, categorized as slow (<-0.25 D), moderate (-0.25 to -0.75 D), or rapid (> -0.75 D). The multiple linear regression evaluated the association between myopic progression and characters.
resultsNo significant differences in age, SE, or sex were found among the groups at baseline. At one year, the magnitude of myopic progression was significantly smaller in the DIMS (-0.47 ± 0.39 D, 33.8 %) groups and MFSCLs (-0.39 ± 0.47 D, 45.1 %) compared to the SVL group (-0.71 ± 0.54 D; P < 0.001). The proportion of slow progressors was 28.40 % (SVLs), 39.81 % (DIMS), and 51.67 % (MFSCLs). Age was associated with the myopic progression in the DIMS (β=0.108, P < 0.001) and SVLs (β=0.120, P < 0.001) group, but not in the MFSCLs (P=0.776) group. MFSCLs were preferred for children under 12 years, while DIMS and MFSCLs showed comparable efficacy for those over 12 with high myopia.
conclusionsBoth MFSCLs and DIMS have demonstrated efficacy in delaying myopic progression in children with high myopia. The MFSCLs will give children better control up to the age of 12; after that, they remain a good option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.